Pasar al contenido principal

REGULACION HIPOTALAMICA DE LA MEMORIA DE MIEDO Y HORMONAS SEXUALES

PID2023-146521OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The PAC1 receptor risk genotype does not influence fear acquisition, extinction, or generalization in women with no trauma/low trauma

  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Fabregat Nabás, Jaime|||0000-0002-5040-0913
  • Torrents-Rodas, David|||0000-0003-0222-7770
  • Arias, Barbara|||0000-0001-9181-2132
  • Torrúbia, Rafael|||0000-0002-6826-6572
  • Fullana, Miguel|||0000-0003-3863-5223
  • Andero Galí, Raül|||0000-0003-3641-8903
Women are known to have twice as much lifetime prevalence of post-traumatic stress disorder (PTSD) as men do. It has been reported that the risk genotype (CC) of a single nucleotide polymorphism (SNP) (rs2267735) in the pituitary adenylate cyclase-activating polypeptide (PACAP-PAC1R) system is associated with PTSD risk and altered fear conditioning and fear extinction in women. Surprisingly, no previous work has studied the effect of this SNP on fear conditioning, extinction, or generalization in non-traumatized/low trauma load women. Here, two separate groups of women underwent either a two-day fear conditioning and fear extinction paradigm, or a one-day fear conditioning and fear generalization paradigm. Results showed no significant differences between genotypes in conditioned stimulus discrimination, during fear acquisition, extinction, or generalization. These findings suggest that the previously reported fear processing impairments in traumatized CC women are not a consequence of this genotype alone, but likely dependent on the interaction between this genetic risk and the exposure to traumatic stressors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The role of Fezolinetant in fear memory consolidation

  • Gallio Fronza, Mariana|||0000-0001-8977-3090
  • Torrent Bonilla, Marta
  • Andero Galí, Raül|||0000-0003-3641-8903
Modulation of fear memories has important implications for the treatment of different psychiatric disorders including fear-based disorders such as posttraumatic stress disorder (PTSD). The Tachykinin2 (Tac2)/Neurokinin B (NkB)/neurokinin 3 receptor (Nk3R) pathway is a potential candidate for treating fear-based disorders built on animal and human studies. Here we demonstrate that the Nk3R antagonist Fezolinetant presents sex-divergent effects in the processing of fear memories in mice exposed to cued-fear conditioning. Fezolinetant (1 and 10 mg/kg, intraperitoneally (i.p.)) administered 30 min after the fear acquisition impairs the fear memory consolidation in male mice, as measured by fear expression 24 h later, showing no effects in naturally cycling female mice, with no monitoring the estrous cycle. However, when the estrous cycle was monitored, Fezolinetant (1 and 10 mg/kg, i.p.) enhanced fear memory consolidation during the proestrus phase, which suggests an effect dependent on high levels of the sex hormones estradiol and/or progesterone. Considering that Fezolinetant is currently a treatment for hot flashes in menopausal women, our results could be rapidly translated into clinical trials focused on treating or preventing fear-based disorders. Thus, these findings support the role of Tac2/NkB/Nk3R in fear memory consolidation and emphasize the importance of considering sex differences in the neurobiology of memory-related processes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stress-induced changes in the molecular processes underlying fear memories, implications for PTSD and relevant animal models

  • Andero Galí, Raül|||0000-0003-3641-8903
Most of the fear literature on humans and animals tests healthy individuals. However, fear memories can differ between healthy individuals and those previously exposed to traumatic stress, such as a car accident, sexual abuse, military combat and personal assault. Traumatic stress can lead to post-traumatic stress disorder (PTSD) which presents alterations in fear memories, such as an impairment of fear extinction and extinction recall. PTSD-like animal models are exposed to a single highly stressful experience in the laboratory, such as stress immobilization or single-prolonged stress. Some days later, animals exposed to a PTSD-like model can be tested in fear procedures that help uncover molecular mechanisms of fear memories. In this review, there are discussed the molecular mechanisms in stress-induced fear memories of patients with PTSD and PTSD-like animal models. The focus is on the effects of estradiol and cortisol/corticosterone hormones and of different genes, such as FKBP prolyl isomerase 5 gene (FKBP5) - FK506 binding protein 51 (FKBP51), pituitary adenylate cyclase-activating peptide (PACAP) - pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1R), endocannabinoid (eCB) system and the tropomyosin receptor kinase B (TrkB) - brain-derived neurotrophic factor (BDNF). The conclusion is that greater emphasis should be placed on investigating the molecular mechanisms of fear memories in PTSD, through direct testing of patients with PTSD or the use of relevant PTSD-like models.